Public recall detail

Health Canada issues label change on the AstraZeneca and COVISHIELD COVID-19 vaccines

medium
Recall Safety notice
Quick summary

Quick summary: Health Canada issues label change on the AstraZeneca and COVISHIELD COVID-19 vaccines .

Recommended action

Recommended action: compare your product with the official notice and follow the instructions published by the official source.

Recall details

Quick summary: Health Canada issues label change on the AstraZeneca and COVISHIELD COVID-19 vaccines .

Official details

Affected product details

Structured information extracted from the official recall notice. Confirm the identifiers and instructions in the original notice.

Brand

Issue

June 29, 2021

What you should do

  • shortness of breath
  • chest pain
  • leg swelling
  • persistent abdominal (belly) pain
  • neurological symptoms, such as severe and persistent worsening headaches or blurred vision
  • skin bruising or tiny blood spots under the skin beyond the site of the injection.
Additional official information
Background{}
Companies
Audiences

Contains information licensed under the Open Government Licence – Canada. SafetyPulse is independent of the Government of Canada.

Starting...

Related recalls

Similar recalls and safety notices.

Loading related recalls...